BGLC - BioNexus Gene Lab Corp
2.5
-0.080 -3.200%
Share volume: 5,706
Last Updated: 03-06-2026
Healthcare/Services – Health:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$2.58
-0.08
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-15-2024 | 05-15-2025 | 11-14-2025 | |
| Assets | ||||||
| Total Assets | 11.161 M | 11.140 M | 10.995 M | 9.480 M | 7.621 M | |
| Current Assets | 7.905 M | 7.843 M | 7.039 M | 6.542 M | 5.627 M | |
| Inventories | 1.077 M | 1.033 M | 1.389 M | 1.179 M | 1.007 M | |
| Other Current Assets | 3.343 M | 3.214 M | 2.076 M | 2.504 M | 1.742 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.489 M | 2.200 M | 2.062 M | 1.091 M | 1.153 M | |
| Total Non-current Assets | 1.656 M | 1.708 M | 1.994 M | 1.213 M | 237.760 K | |
| Property Plant Equipment | 1.472 M | 1.348 M | 1.729 M | 1.520 M | 1.571 M | |
| Other Assets | 1.784 M | 1.949 M | 2.227 M | 1.417 M | 423.842 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 11.161 M | 11.140 M | 10.995 M | 9.480 M | 7.621 M | |
| Total liabilities | 1.817 M | 1.594 M | 1.607 M | 1.708 M | 804.966 K | |
| Total current liabilities | 1.717 M | 1.399 M | 1.415 M | 1.560 M | 678.023 K | |
| Accounts Payable | 1.644 M | 1.125 M | 1.325 M | 1.470 M | 559.980 K | |
| Other liabilities | 88.846 K | 182.697 K | 178.367 K | 147.940 K | 126.943 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 88.846 K | 182.697 K | 178.367 K | 147.940 K | 126.943 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -7.847 M | -7.646 M | -8.268 M | -9.561 M | -10.516 M | |
| Common stock | -5.012 M | -5.012 M | -5.012 M | -5.012 M | -5.012 M | |
| Retained earnings | -1.948 M | -1.749 M | -3.094 M | -4.066 M | -5.391 M |